Works matching IS 11707690 AND DT 2014 AND VI 32 AND IP 10

Results: 11

Comment on "ahead of its time? Reflecting on New Zealand's Pharmac following its 20th anniversary" : clarification from PHARMAC: PHARMAC takes no particular distributive approach (utilitarian or otherwise).

Published in:

2014

By:

Metcalfe, Scott;
Grocott, Rachel;
Rasiah, Dilky

Publication type:

Letter

Network vs. Pairwise Meta-Analyses: A Case Study of the Impact of an Evidence-Synthesis Paradigm on Value of Information Outcomes.

Published in:

PharmacoEconomics, 2014, v. 32, n. 10, p. 995, doi. 10.1007/s40273-014-0179-1

By:

Zafari, Zafar;
Thorlund, Kristian;
FitzGerald, J.;
Marra, Carlo;
Sadatsafavi, Mohsen

Publication type:

Article

Cost-Utility Analysis of Chemotherapy Regimens in Elderly Patients with Stage III Colon Cancer.

Published in:

PharmacoEconomics, 2014, v. 32, n. 10, p. 1005, doi. 10.1007/s40273-014-0180-8

By:

Lairson, David;
Parikh, Rohan;
Cormier, Janice;
Chan, Wenyaw;
Du, Xianglin

Publication type:

Article

Reconceptualising the External Validity of Discrete Choice Experiments.

Published in:

PharmacoEconomics, 2014, v. 32, n. 10, p. 951, doi. 10.1007/s40273-014-0181-7

By:

Lancsar, Emily;
Swait, Joffre

Publication type:

Article

Decision-Analytic Models: Current Methodological Challenges.

Published in:

PharmacoEconomics, 2014, v. 32, n. 10, p. 943, doi. 10.1007/s40273-014-0183-5

By:

Caro, J.;
Möller, Jörgen

Publication type:

Article

Modelling Outcomes of Complex Treatment Strategies Following a Clinical Guideline for Treatment Decisions in Patients with Rheumatoid Arthritis.

Published in:

PharmacoEconomics, 2014, v. 32, n. 10, p. 1015, doi. 10.1007/s40273-014-0184-4

By:

Tran-Duy, An;
Boonen, Annelies;
Kievit, Wietske;
Riel, Piet;
Laar, Mart;
Severens, Johan

Publication type:

Article

Avoiding and Identifying Errors and Other Threats to the Credibility of Health Economic Models.

Published in:

PharmacoEconomics, 2014, v. 32, n. 10, p. 967, doi. 10.1007/s40273-014-0186-2

By:

Tappenden, Paul;
Chilcott, James

Publication type:

Article

Model-Based Cost-Effectiveness Analyses for the Treatment of Chronic Lymphocytic Leukaemia: A Review of Methods to Model Disease Outcomes and Estimate Utility.

Published in:

PharmacoEconomics, 2014, v. 32, n. 10, p. 981, doi. 10.1007/s40273-014-0187-1

By:

Marsh, Kevin;
Xu, Peng;
Orfanos, Panagiotis;
Gordon, James;
Griebsch, Ingolf

Publication type:

Article

Comment on 'Ahead of Its Time? Reflecting on New Zealand's Pharmac Following its 20th Anniversary'.

Published in:

PharmacoEconomics, 2014, v. 32, n. 10, p. 1031, doi. 10.1007/s40273-014-0208-0

By:

Metcalfe, Scott;
Grocott, Rachel;
Rasiah, Dilky

Publication type:

Article

Erratum to: Modelling the Cost Effectiveness of Interventions for Osteoporosis: Issues to Consider.

Published in:

PharmacoEconomics, 2014, v. 32, n. 10, p. 1029, doi. 10.1007/s40273-014-0213-3

By:

Stevenson, Matt;
Selby, Peter

Publication type:

Article

Ahead of Its Time? Reflecting on New Zealand's Pharmac Following Its 20th Anniversary.

Published in:

PharmacoEconomics, 2014, v. 32, n. 10, p. 937, doi. 10.1007/s40273-014-0178-2

By:

Gauld, Robin

Publication type:

Article